National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE): Meeting, 4513 [E7-1493]
Download as PDF
<![CDATA[
4513
Federal Register / Vol. 72, No. 20 / Wednesday, January 31, 2007 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form
Respondents
Web-based survey on CVH Toolkit ..
State Heart Disease and Stroke
Programs.
Dated: January 25, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–1489 Filed 1–30–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Cooperative
Agreement for Enhancing Public
Health Practice Related to Birth
Defects and Developmental
Disabilities, Request for Application
(RFA) DD07–002 and Cooperative
Agreement for a National Research
and Training Organization for People
With Developmental and Other
Disabilities, RFA DD07–003
mstockstill on PROD1PC62 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned SEP:
Time and Date: 1 p.m.–4 p.m., March 19,
2007 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to Be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to RFA DD07–002, ‘‘Cooperative
Agreement for Enhancing Public Health
Practice Related to Birth Defects and
Developmental Disabilities,’’ and RFA DD07–
003, ‘‘Cooperative Agreement for a National
Research and Training Organization for
People with Developmental and other
Disabilities.’’
Contact Person for More Information:
Juliana Cyril, PhD, Associate Director for
Policy and Peer Review, Centers for Disease
Control and Prevention, 1600 Clifton Road,
NE., Mailstop D72, Atlanta, GA 30333,
Telephone 404.639.4639.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
VerDate Aug<31>2005
15:08 Jan 30, 2007
Jkt 211001
51
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–1501 Filed 1–30–07; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Task Force on Fetal Alcohol
Syndrome and Fetal Alcohol Effect
(NTFFASFAE): Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned Federal advisory
committee.
Times and Dates: 8:30 a.m.–4:30 p.m.,
February 28, 2007. 8:30 a.m.–1 p.m., March
1, 2007.
Place: SpringHill Suites Atlanta Buckhead,
3459 Buckhead Loop, NE., Atlanta, Georgia
30326, telephone 404/844–4800, fax 404/
844–4801.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 80 people.
Purpose: The Secretary is authorized by the
Public Health Service Act, Section 399G, (42
U.S.C. 280f, as added by Pub. L. 105–392) to
establish a National Task Force on Fetal
Alcohol Syndrome and Fetal Alcohol Effect
to: (1) foster coordination among all
governmental agencies, academic bodies and
community groups that conduct or support
Fetal Alcohol Syndrome (FAS) and Fetal
Alcohol Effect (FAE) research, programs and
surveillance; and (2) to otherwise meet the
general needs of populations actually or
potentially impacted by FAS and FAE.
Matters to Be Discussed: Agenda items
include: Presentation of draft report on
evidence-based fetal alcohol spectrum
disorders (FASD) community-based
prevention strategies with deliberations by
the Task Force; presentation on U.S.
Preventive Services Task Force report on
alcohol use screening and behavioral
counseling interventions; report on work of
Post-exposure working group regarding
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden
per response
(in hrs.)
1
Total burden
(in hours)
0.5
25.5
recommendations for future directions in
FASD policy and research; updates from the
Interagency Coordinating Committee on FAS,
the CDC and other Federal agencies, and
liaison representatives; and scheduling of the
next meeting.
Agenda items are subject to change as
priorities dictate.
For Further Information Contact: Mary
Kate Weber, M.P.H., Designated Federal
Official, National Center on Birth Defects and
Developmental Disabilities, CDC, 1600
Clifton Road, NE., (E–86), Atlanta, Georgia
30333, telephone 404/498–3926, fax 404/
498–3550.
The Acting Director, Management Analysis
and Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and ATSDR.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–1493 Filed 1–30–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices: Meeting
Correction: This notice was published
in the Federal Register on December 8,
2006, Volume 71, Number 236, page
71175–71176. The matters to be
discussed have changed.
Matters To Be Discussed: The agenda
will include discussions on influenza
vaccine; immunization safety; update on
use of rotavirus vaccine; update on use
of HPV vaccine; update on use of herpes
zoster (shingles) vaccine; vaccine
supply; Japanese encephalitis and other
flavivirus vaccines (e.g., yellow fever
vaccine); diphtheria, tetanus, pertussis,
polio, Haemophilus B [Hib]
combination vaccine (Pentacel);
evidence-based recommendations; and
agency updates. Vaccine for Children
votes will be on hepatitis A post
exposure prophylaxis, influenza and
Pentacel. Agenda items are subject to
change as priorities dictate.
E:\FR\FM\31JAN1.SGM
31JAN1
]]>Agencies
[Federal Register Volume 72, Number 20 (Wednesday, January 31, 2007)]
[Notices]
[Page 4513]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-1493]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol
Effect (NTFFASFAE): Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
Federal advisory committee.
Times and Dates: 8:30 a.m.-4:30 p.m., February 28, 2007. 8:30
a.m.-1 p.m., March 1, 2007.
Place: SpringHill Suites Atlanta Buckhead, 3459 Buckhead Loop,
NE., Atlanta, Georgia 30326, telephone 404/844-4800, fax 404/844-
4801.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 80 people.
Purpose: The Secretary is authorized by the Public Health
Service Act, Section 399G, (42 U.S.C. 280f, as added by Pub. L. 105-
392) to establish a National Task Force on Fetal Alcohol Syndrome
and Fetal Alcohol Effect to: (1) foster coordination among all
governmental agencies, academic bodies and community groups that
conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol
Effect (FAE) research, programs and surveillance; and (2) to
otherwise meet the general needs of populations actually or
potentially impacted by FAS and FAE.
Matters to Be Discussed: Agenda items include: Presentation of
draft report on evidence-based fetal alcohol spectrum disorders
(FASD) community-based prevention strategies with deliberations by
the Task Force; presentation on U.S. Preventive Services Task Force
report on alcohol use screening and behavioral counseling
interventions; report on work of Post-exposure working group
regarding recommendations for future directions in FASD policy and
research; updates from the Interagency Coordinating Committee on
FAS, the CDC and other Federal agencies, and liaison
representatives; and scheduling of the next meeting.
Agenda items are subject to change as priorities dictate.
For Further Information Contact: Mary Kate Weber, M.P.H.,
Designated Federal Official, National Center on Birth Defects and
Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E-86),
Atlanta, Georgia 30333, telephone 404/498-3926, fax 404/498-3550.
The Acting Director, Management Analysis and Services Office,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee
management activities for both the CDC and ATSDR.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-1493 Filed 1-30-07; 8:45 am]
BILLING CODE 4163-18-P
